Using Liquid Foundation Models with Liquid Biopsy data in a Spatial-to-Spatial AI framework has the potential to revolutionize cancer diagnosis, monitoring, and treatment. This approach bridges the gap between molecular changes detected in the blood and their spatial context within the tumor, allowing for a comprehensive understanding of cancer dynamics and improving precision oncology.